Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 4Thoracic 2Other 2Gastrointestinal 2Tumor-Agnostic 1Lymphoid 1Head & Neck 1Gynecologic 1Endocrine 1

Conditions

Uterine Cervical Neoplasms 1Ovarian Neoplasms 1Endometrial Neoplasms 1

Interventions

Paclitaxel 581Carboplatin 528Cisplatin 359Bevacizumab 256pembrolizumab 228Gemcitabine 157liposomal doxorubicin 132Topotecan 131olaparib 129Cyclophosphamide 128Radiotherapy 118Taxes 114Docetaxel 95Brachytherapy 94Drug Therapy 91niraparib 88Doxorubicin 86Surveys and Questionnaires 85Magnetic Resonance Spectroscopy 80Blood Specimen Collection 74Nivolumab 71Specimen Handling 70Hyperthermic Intraperitoneal Chemotherapy 64Biopsy 63fludarabine 57Filgrastim 53Letrozole 50Oxaliplatin 49durvalumab 47Immunoglobulin G 47

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Anti-Inflammatory Agents, Non-Steroidal × Gynecologic × Clear all
NCT01705288 2020-02-17

Implementation of a Rapid Recovery Program in Gynecologic Oncology Surgery: A Pilot Study

Masonic Cancer Center, University of Minnesota

Phase EARLY_PHASE1 Completed
103 enrolled 9 charts
Gynecologic

Uterine Cervical Neoplasms, Ovarian Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡